| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |